Fig. 1

VF defect (detected by Humphrey Visual Field Analyser 30–2) significantly subsided after one month of IVI of Ozurdex. (a, b) VF on the next day after onset of symptoms. (OD: Fixation losses: 1/21, false positive errors: 5% and false negative errors: 6%. OS: Fixation losses: 0/21, false positive errors: 0% and false negative errors: 5%) (c, d) One month after IVI, VF defect significantly subsided of both eyes. (OD: Fixation losses: 0/19, false positive errors: 4% and false negative errors: 7%. OS: Fixation losses: 1/21, false positive errors: 0% and false negative errors: 1%)